References
- Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R. and Ball, S. E. : Drugdrug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug. Metab. Dispos. 32, 1201 (2004).
- Guengerich, F. P. : Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 21, 70 (2008). https://doi.org/10.1021/tx700079z
- Kim, S. K. and Novak, R. F. : The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol. Ther. 11, 88 (2007).
- Guengerich, F. P. : Role of cytochrome P450 enzymes in drug_drug interactions. Adv. Pharmacol. 43, 7 (1997). https://doi.org/10.1016/S1054-3589(08)60200-8
- U.S. Food and drug administration: Draft FDA Guidance for Industry, Drug Interaction Studies - Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations (2012).
- Lee, K. S. and Kim, S. K. : Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions. J. Appl. Toxicol. 33, 100 (2013). https://doi.org/10.1002/jat.1720
- Lee, J. Y., Lee, S. Y., Oh, S. J., Lee, K. H., Jung, Y. S. and Kim, S. K. : Assessment of drug-drug interactions caused by metabolism-dependent cytochrome P450 inhibition. Chem. Biol. Interact. 198, 49 (2012). https://doi.org/10.1016/j.cbi.2012.05.007
- Lee, S. Y., Lee, J. Y., Kang, W., Kwon, K. I., Park, S. K., Oh, S. J., Ma, J. Y. and Kim, S. K. : Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. Food Chem. Toxicol. 51, 343 (2013). https://doi.org/10.1016/j.fct.2012.10.012
- Lee, S. Y., Lee, J. Y., Kang, W., Kwon, K. I., Oh, S. J., Ma, J. Y. and Kim, S. K. : In vitro and in vivo assessment of cytochrome P450-mediated herb-drug interaction of Ssang-hwa-tang Food Chem. 136, 450 (2013). https://doi.org/10.1016/j.foodchem.2012.08.069
- Pfizer Labs : Insert paper of Zyrtec (cetirizine hydrochloride) (2006) http://www.pfizer.com/files/products/uspi_zyrtec.pdf.
- Villacampa, J., Alcantar, F., Rodriguez, J. M., Morales, J. M., Herrera, J. and Rosete, R. : Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men. Clin. Ther. 25, 2225 (2003). https://doi.org/10.1016/S0149-2918(03)80215-1
- Guengerich, F. P., Kim, D. H. and Iwasaki, M. : Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168 (1991). https://doi.org/10.1021/tx00020a008
- Laethem, R. M., Balazy, M., Falck, J. R., Laethem, C. L., Koop, D. R. : Formation of 19(S)-, 19(R)-, and 18(R)- hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J. Biol. Chem. 268, 12912 (1993).